J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morimoto, T.
Right arrow Articles by Nakano, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morimoto, T.
Right arrow Articles by Nakano, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

DRUG INTERACTIONS

Effect of St. John's Wort on the Pharmacokinetics of Theophylline in Healthy Volunteers

Takuya Morimoto, MD, Tsutomu Kotegawa, MD, PhD, Kimiko Tsutsumi, PhD, Yasukiyo Ohtani, MD, PhD, Hiromitsu Imai, MD and Shigeyuki Nakano, MD, PhD, FCP

From the Department of Clinical Pharmacology and Therapeutics, Oita Medical University, Oita, Japan (Dr. Morimoto, Dr. Tsutsumi, Dr. Imai, Dr. Nakano) and the Clinical Pharmacology Center, Oita Medical University Hospital, Oita, Japan (Dr. Kotegawa, Dr. Ohtani, Dr, Nakano).

The objective of this study was to investigate the effect of St. John's wort (SJW, Hypericum perforatum) on the pharmacokinetics of theophylline in healthy volunteers. Twelve healthy Japanese male volunteers participated in this randomized, open-labeled, crossover study. The subjects took an SJW caplet (300 mg) three times a day for 15 days. On day 14, they received a single oral dose of 400 mg of theophylline. They took the same dose of theophylline without SJW treatment on another occasion. Plasma and urine samples were obtained during a 48-hour period after theophylline administration. Theophylline concentrations in plasma and urine, as well as the major metabolites (13U, 1U, 3X) in urine, were measured. SJW caused no significant changes in the pharmacokinetics of theophylline in plasma. SJW administration tended to increase the ratio of 1U/the total amount excreted in urine. However, no changes in the ratio of unchanged theophylline, 13U, and 3X were observed. It is unlikely that the effect of 15 days of treatment with SJW on CYPs is sufficient to cause a change in plasma theophylline concentrations.


Key Words: St. John's worttheophyllinedrug metabolismpharmacokineticsherb-drug interactions

Address for reprints: Tsutomu Kotegawa, MD, PhD, Clinical Pharmacology Center, Oita Medical University Hospital, Hasama-machi, Oita 879-5593, Japan.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BMJHome page
E. Mills, V. M Montori, P. Wu, K. Gallicano, M. Clarke, and G. Guyatt
Interaction of St John's wort with conventional drugs: systematic review of clinical trials
BMJ, July 3, 2004; 329(7456): 27 - 30.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Sparreboom, M. C. Cox, M. R. Acharya, and W. D. Figg
Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
J. Clin. Oncol., June 15, 2004; 22(12): 2489 - 2503.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
L.-S. Wang, B. Zhu, A. M. A. El-Aty, G. Zhou, Z. Li, J. Wu, G.-L. Chen, J. Liu, Z. R. Tang, W. An, et al.
The Influence of St. John's Wort on CYP2C19 Activity with Respect to Genotype
J. Clin. Pharmacol., June 1, 2004; 44(6): 577 - 581.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Clinical Pharmacology